Molecular aspects of microcystin-induced hepatotoxicity and hepatocarcinogenesis

Z Svircev1, V Baltić, M Gantar

  • 1Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Serbia. zorica.svircev@dbe.uns.ac.rs

Insights

Microcystins (MC) are cyanotoxins that promote and initiate liver cancer by damaging DNA and causing cell proliferation or apoptosis. Chronic exposure to MC in drinking water increases primary liver cancer risk.

Area of Science:

  • Environmental Toxicology
  • Hepatocarcinogenesis
  • Cyanobacterial Toxinology

Background:

  • Microcystins (MC) are cyanotoxins inhibiting protein phosphatases 1 and 2A.
  • MC are classified as potential carcinogens (IARC group 2B) and tumor promoters.
  • MC-LR can induce DNA damage directly or via reactive oxygen species (ROS), potentially initiating tumors.

Purpose of the Study:

  • To review the genotoxicity and hepatocarcinogenic mechanisms of microcystins (MC).
  • To evaluate the role of MC in primary liver cancer (PLC) initiation and promotion.
  • To investigate MC's effects on hepatocytes, including proliferation and apoptosis.

Main Methods:

  • Review of existing literature on MC toxicity and carcinogenicity.
  • Analysis of epidemiological data linking MC exposure to PLC.
  • In vitro studies on MC-induced DNA damage and cellular responses in hepatocytes.

Main Results:

  • MC exposure, both acute and chronic, activates apoptotic pathways.
  • Chronic low-dose MC exposure increases cancer risk.
  • Epidemiological studies correlate MC blooms in water sources with high PLC incidence.

Conclusions:

  • MC can act as both an initiator and promoter of primary liver cancer (PLC).
  • MC-LR may initiate and promote PLC independently of co-factors like aflatoxin or viral infections.
  • Hepatocyte exposure to MC can result in malignant proliferation or apoptosis, contributing to hepatocarcinogenesis.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...